Education and Training
MD - Florida State University, Tallahassee, FL
Pediatrics - Nicklaus Miami Children's Hospital, Miami, FL
Pediatric Hematology-Oncology - Children's Hospital of Philadelphia, Philadelphia, PA
Clinical Pharmacology and Experimental Therapeutics - Thomas Jefferson University, Philadelphia, PA
MS in Pharmacology - Thomas Jefferson University, Philadelphia, PA
Titles and Academic Titles
Instructor in Pediatrics, Division of Oncology, Perelman School of Medicine at the University of Pennsylvania
Departments and Services
Zapata C, Hogarty M. : Bcl2-family inhibitors in Neuroblastoma. Seventh Annual Meeting of NICHD and NICHD-NIGMS T32 Trainees in Pediatric Clinical Pharmacology August 2018.
Zapata C., Coku J., Liu K., Vu A., Goutnik M., Reynolds P., Goldsmith K., Hogarty M.: Bcl2-family inhibitors for Neuroblastoma: Mechanism of activity and biomarker development. Advances in Neuroblastoma Research Congress May 2018.
Posters and Presentations
Zapata C. Targeting Apoptosis Resistance in Neuroblastoma. K30 Conference, Departmental Research Seminar. Department of Pharmacology Seminars in Human investigation, Thomas Jefferson University, Philadelphia, PA. Oct, 2018.
Zapata C. Bcl2-family inhibitors in Neuroblastoma. Annual Pediatric Clinical Pharmacology T32 meeting, Bethesda, MD. Aug, 2018.
Zapata C. Bcl2-inhibitor (Venetoclax) for Neuroblastoma. K30 Conference, Journal Club.Department of Pharmacology Seminars in Human investigation, Thomas Jefferson University, Philadelphia, PA. Jun, 2018.
Zapata C. MLL rearrangement in ALL: Case presentation. Molecular Tumor Board presentation, Children's Hospital of Philadelphia, Philadelphia, PA. Jun, 2017.
Awards and Honors
2017-present, Clinical Pharmacology T32 Awardee, Children's Hospital of Philadelphia and Thomas Jefferson University
2015, Nicklaus Miami Children's Hospital 7th Annual Scholarship Day, 2nd Place Original Research
2015, Nicklaus Miami Children's Hospital 7th Annual Scholarship Day, 1st Place Original Research
2013, Alpha Omega Alpha Honor Medical Society
2013, FSU Regional Campus Dean's Award
2013, FSU Excellence in Pediatrics Award
2013, AMWA Glasglow Rubin Achievement Award
2013, Gold Humanism Honor Society
2011-2013, FSU COM Mission Scholarship
;2010-2011, FSU COM Summer Research Fellowship
2009-2011, FSU COM Dean's Award Scholarship
2008, Summa Cum Laude, Florida Atlantic University
2007, Golden Key Honor Society
2005-2008, FAU President's Honor List
2005, The National Society of Collegiate Scholar
Leadership and Memberships
Memberships in Professional Organizations
2018-present, American Society of Clinical Pharmacology and Therapeutics
2018-present, American Academy of Cancer Research
2017-present, American Society of Pediatric Hematology-Oncology
2016-present, Children's Oncology Group
2013-present, American Academy of Pediatrics
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.